Literature DB >> 15337406

A population-based nationwide study of parents' perceptions of a questionnaire on their child's death due to cancer.

Ulrika Kreicbergs1, Unnur Valdimarsdóttir, Gunnar Steineck, Jan-Inge Henter.   

Abstract

A proposed nationwide postal questionnaire to Swedish parents who had lost a child due to cancer between 1992 and 1997 was denied approval by the local ethics committee. However, a pilot study to assess the harm and benefit of the questionnaire was approved. 95% of parents found the pilot study valuable; thus, we were allowed to proceed with the main study, which consisted of 129 questions about the child's care and death and five about the parents' perceptions of the study. 423 (99%) parents found the investigation valuable, 285 (68%) were positively affected, and 123 (28%) were negatively affected (10 [2%] of whom, very much). Although the numerical data cannot be directly translated to ethical conclusions, they can provide guidance for future ethical decisions.

Entities:  

Keywords:  Biomedical and Behavioral Research; Death and Euthanasia; Empirical Approach

Mesh:

Year:  2004        PMID: 15337406     DOI: 10.1016/S0140-6736(04)16939-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  Identifying obstacles to participation in a questionnaire survey on widowers' grief.

Authors:  Bragi Skulason; Asgeir R Helgason
Journal:  BMC Palliat Care       Date:  2010-04-29       Impact factor: 3.234

2.  Adherence to medication: A nation-wide study from the Children's Cancer Hospital, Egypt.

Authors:  Hanan El Malla; Nathalie Ylitalo Helm; Ulrica Wilderäng; Yasser El Sayed Elborai; Gunnar Steineck; Ulrika Kreicbergs
Journal:  World J Psychiatry       Date:  2013-06-22

3.  The Benefits and Burdens of Pediatric Palliative Care and End-of-Life Research: A Systematic Review.

Authors:  Meaghann S Weaver; Kim Mooney-Doyle; Katherine Patterson Kelly; Kathleen Montgomery; Amy R Newman; Christine A Fortney; Cynthia J Bell; Jessica L Spruit; Melissa Kurtz Uveges; Lori Wiener; Cynthia M Schmidt; Vanessa N Madrigal; Pamela S Hinds
Journal:  J Palliat Med       Date:  2019-03-05       Impact factor: 2.947

4.  Participation in Online Research Examining End-of-Life Experiences: Is It Beneficial, Burdensome, or Both for Parents Bereaved by Childhood Cancer?

Authors:  Julia Tager; Haven Battles; Sima Zadeh Bedoya; Cynthia A Gerhardt; Tammi Young-Saleme; Lori Wiener
Journal:  J Pediatr Oncol Nurs       Date:  2019 May/Jun       Impact factor: 1.636

Review 5.  Systematic review of psychosocial morbidities among bereaved parents of children with cancer.

Authors:  Abby R Rosenberg; K Scott Baker; Karen Syrjala; Joanne Wolfe
Journal:  Pediatr Blood Cancer       Date:  2011-10-28       Impact factor: 3.167

6.  Ostomy function after abdominoperineal resection--a clinical and patient evaluation.

Authors:  E Angenete; A Correa-Marinez; J Heath; E González; A Wedin; M Prytz; D Asplund; E Haglind
Journal:  Int J Colorectal Dis       Date:  2012-03-27       Impact factor: 2.571

7.  Research participation experiences of parents of children with cancer who were asked about their child's prognosis.

Authors:  Maura E Olcese; Jennifer W Mack
Journal:  J Palliat Med       Date:  2012-02-17       Impact factor: 2.947

Review 8.  Designing and implementing a longitudinal study of children with neurological, genetic or metabolic conditions: charting the territory.

Authors:  Harold Siden; Rose Steele; Rollin Brant; Susan Cadell; Betty Davies; Lynn Straatman; Kimberley Widger; Gail S Andrews
Journal:  BMC Pediatr       Date:  2010-09-20       Impact factor: 2.125

9.  Approaching the third decade of paediatric palliative oncology investigation: historical progress and future directions.

Authors:  Abby R Rosenberg; Joanne Wolfe
Journal:  Lancet Child Adolesc Health       Date:  2017-07-24

10.  Emotional risks to respondents in survey research.

Authors:  Susan M Labott; Timothy P Johnson; Michael Fendrich; Norah C Feeny
Journal:  J Empir Res Hum Res Ethics       Date:  2013-10       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.